Gietema JA - Search Results

1

Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk.

Grasso C, Popovic M, Isaevska E, Lazzarato F, Fiano V, Zugna D, Pluta J, Weathers B, D'Andrea K, Almstrup K, Anson-Cartwright L, Bishop DT, Chanock SJ, Chen C, Cortessis VK, Dalgaard MD, Daneshmand S, Ferlin A, Foresta C, Frone MN, Gamulin M, Gietema JA, Greene MH, Grotmol T, Hamilton RJ, Haugen TB, Hauser R, Karlsson R, Kiemeney LA, Lessel D, Lista P, Lothe RA, Loveday C, Meijer C, Nead KT, Nsengimana J, Skotheim RI, Turnbull C, Vaughn DJ, Wiklund F, Zheng T, Zitella A, Schwartz SM, McGlynn KA, Kanetsky PA, Nathanson KL, Richiardi L. Grasso C, et al. Among authors: gietema ja. Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1769-1779. doi: 10.1158/1055-9965.EPI-22-0123. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35700037 Free PMC article.

2

Non-germ cell malignancy in residual or recurrent mass after chemotherapy for nonseminomatous testicular germ cell tumor.

Lutke Holzik MF, Hoekstra HJ, Mulder NH, Suurmeijer AJ, Sleijfer DT, Gietema JA. Lutke Holzik MF, et al. Among authors: gietema ja. Ann Surg Oncol. 2003 Mar;10(2):131-5. doi: 10.1245/aso.2003.05.024. Ann Surg Oncol. 2003. PMID: 12620907

3

Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients.

Nuver J, Lutke Holzik MF, van Zweeden M, Hoekstra HJ, Meijer C, Suurmeijer AJ, Groen HJ, Hofstra RM, Sluiter WJ, Groen H, Sleijfer DT, Gietema JA. Nuver J, et al. Among authors: gietema ja. Pharmacogenet Genomics. 2005 Jun;15(6):399-405. doi: 10.1097/01213011-200506000-00005. Pharmacogenet Genomics. 2005. PMID: 15900213

4

Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.

de Haas EC, Zwart N, Meijer C, Nuver J, Boezen HM, Suurmeijer AJ, Hoekstra HJ, van der Steege G, Sleijfer DT, Gietema JA. de Haas EC, et al. Among authors: gietema ja. J Clin Oncol. 2008 Apr 10;26(11):1817-23. doi: 10.1200/JCO.2007.14.1606. J Clin Oncol. 2008. PMID: 18398146

5

Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.

de Haas EC, di Pietro A, Simpson KL, Meijer C, Suurmeijer AJ, Lancashire LJ, Cummings J, de Jong S, de Vries EG, Dive C, Gietema JA. de Haas EC, et al. Among authors: gietema ja. Neoplasia. 2008 Oct;10(10):1041-8. doi: 10.1593/neo.08620. Neoplasia. 2008. PMID: 18813353 Free PMC article.

6

Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro.

Nuver J, De Haas EC, Van Zweeden M, Gietema JA, Meijer C. Nuver J, et al. Among authors: gietema ja. Oncol Rep. 2010 Jan;23(1):247-53. Oncol Rep. 2010. PMID: 19956889

7

Association of PAI-1 gene polymorphism with survival and chemotherapy-related vascular toxicity in testicular cancer.

de Haas EC, Zwart N, Meijer C, Suurmeijer AJ, Meijer K, Guchelaar HJ, Hoekstra HJ, van Leeuwen FE, Sleijfer DT, Boezen HM, Gietema JA. de Haas EC, et al. Among authors: gietema ja. Cancer. 2010 Dec 15;116(24):5628-36. doi: 10.1002/cncr.25300. Epub 2010 Aug 24. Cancer. 2010. PMID: 20737565 Free article.

8

Laparoscopic resection of a residual retroperitoneal tumor mass of nonseminomatous testicular germ cell tumors.

Oztürk C, van Ginkel RJ, Krol RM, Gietema JA, Hofker HS, Hoekstra HJ. Oztürk C, et al. Among authors: gietema ja. Surg Endosc. 2012 Feb;26(2):458-67. doi: 10.1007/s00464-011-1901-0. Epub 2011 Sep 23. Surg Endosc. 2012. PMID: 21938584 Free PMC article.

9

Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.

Schaapveld M, van den Belt-Dusebout AW, Gietema JA, de Wit R, Horenblas S, Witjes JA, Hoekstra HJ, Kiemeney LA, Louwman WJ, Ouwens GM, Aleman BM, van Leeuwen FE. Schaapveld M, et al. Among authors: gietema ja. Br J Cancer. 2012 Oct 23;107(9):1637-43. doi: 10.1038/bjc.2012.448. Epub 2012 Oct 11. Br J Cancer. 2012. PMID: 23059747 Free PMC article.

10

Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage.

Altena R, Fehrmann RS, Boer H, de Vries EG, Meijer C, Gietema JA. Altena R, et al. Among authors: gietema ja. PLoS One. 2015 Jan 15;10(1):e0115372. doi: 10.1371/journal.pone.0115372. eCollection 2015. PLoS One. 2015. PMID: 25590623 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page